NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 264 filers reported holding NOVOCURE LTD in Q2 2020. The put-call ratio across all filers is 1.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $1,000 | -100.0% | 19 | -99.9% | 0.00% | -100.0% |
Q4 2020 | $4,118,000 | -79.9% | 23,800 | -87.1% | 0.02% | -81.2% |
Q3 2020 | $20,526,000 | -42.7% | 184,400 | -65.3% | 0.08% | -50.6% |
Q1 2020 | $35,818,000 | +2234.9% | 531,892 | +2822.5% | 0.17% | +3340.0% |
Q4 2019 | $1,534,000 | – | 18,200 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
StepStone Group LP | 115,479 | $7,302,000 | 11.05% |
HARTLINE INVESTMENT CORP/ | 335,585 | $21,219,000 | 5.07% |
Darsana Capital Partners LP | 1,500,000 | $94,845,000 | 3.08% |
Rhenman & Partners Asset Management AB | 365,899 | $23,136,000 | 2.55% |
COURAGE CAPITAL MANAGEMENT LLC | 20,000 | $1,265,000 | 2.15% |
Taylor Frigon Capital Management LLC | 46,599 | $2,946,000 | 2.04% |
Granite Investment Partners, LLC | 411,659 | $26,029,000 | 1.40% |
Nicholas Investment Partners, LP | 146,106 | $9,238,000 | 0.85% |
Baillie Gifford | 8,829,449 | $558,287,000 | 0.59% |
Empowered Funds, LLC | 20,936 | $1,324,000 | 0.55% |